Co-Authors
This is a "connection" page, showing publications co-authored by Prabhakar Baliga and James Fleming.
Connection Strength
2.214
-
Fleming JN, Taber DJ, Pilch NA, Mardis CR, Gilbert RE, Wilson LZ, Patel N, Ball S, Mauldin P, Baliga PK. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659.
Score: 0.704
-
Fleming JN, Taber DJ, Weimert NA, Egidi MF, McGillicuddy J, Bratton CF, Lin A, Chavin KD, Baliga PK. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5.
Score: 0.401
-
Rohan VS, Taber DJ, Patel N, Perez C, Pilch N, Parks S, Bolin E, Nadig SN, Baliga PK, Fleming JN. Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients. Clin Transplant. 2020 10; 34(10):e14006.
Score: 0.212
-
Taber DJ, Su Z, Fleming JN, McGillicuddy JW, Posadas-Salas MA, Treiber FA, Dubay D, Srinivas TR, Mauldin PD, Moran WP, Baliga PK. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
Score: 0.175
-
Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).
Score: 0.175
-
Casale JP, Taber DJ, Staino C, Boyle K, Covert K, Pilch NA, Mardis C, Meadows HB, Chavin KD, McGillicuddy JW, Baliga PK, Fleming JN. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients. Pharmacotherapy. 2017 Jun; 37(6):692-699.
Score: 0.169
-
Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD, Bratton CF. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33.
Score: 0.155
-
Veasey TM, Fleming JN, Strout SE, Miller R, Pilch NA, Meadows HB, Mardis CR, Mardis BA, Shenvi S, McGillicuddy J, Chavin KD, Baliga P, Taber DJ. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
Score: 0.042
-
Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, Baliga PK, McGillicuddy JW, Egede LE. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.
Score: 0.041
-
Covert KL, Fleming JN, Staino C, Casale JP, Boyle KM, Pilch NA, Meadows HB, Mardis CR, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK, Taber DJ. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
Score: 0.039
-
Morbitzer KA, Taber DJ, Pilch NA, Meadows HB, Fleming JN, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
Score: 0.034
-
Taber DJ, Spivey JR, Tsurutis VM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Treiber FA, Baliga PK, Chavin KD. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6.
Score: 0.034
-
Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
Score: 0.033